Structure-Based Design of an in Vivo Active Selective BRD9 Inhibitor-Reference-Cited by-同舟云学术

Structure-Based Design of an in Vivo Active Selective BRD9 Inhibitor

Published:2016-03-10 Issue:10 Volume:59 Page:4462-4475
ISSN:0022-2623
Container-title:Journal of Medicinal Chemistry
language:en
Short-container-title:J. Med. Chem.

Author:

Martin Laetitia J.¹,Koegl Manfred¹,Bader Gerd¹,Cockcroft Xiao-Ling¹,Fedorov Oleg²,Fiegen Dennis³,Gerstberger Thomas¹,Hofmann Marco H.¹,Hohmann Anja F.⁴,Kessler Dirk¹,Knapp Stefan²,Knesl Petr¹,Kornigg Stefan¹,Müller Susanne²,Nar Herbert³,Rogers Catherine²,Rumpel Klaus¹,Schaaf Otmar¹,Steurer Steffen¹,Tallant Cynthia²,Vakoc Christopher R.⁴,Zeeb Markus³,Zoephel Andreas¹,Pearson Mark¹,Boehmelt Guido¹,McConnell Darryl¹

Affiliation:

1. Boehringer Ingelheim RCV GmbH & Co KG, Vienna 1121, Austria

2. SGC, University of Oxford, Oxford OX3 7DQ, United Kingdom

3. Boehringer Ingelheim Pharma GmbH & Co KG, Biberach 88400, Germany

4. Cold Spring Harbor Laboratory, Cold Spring Harbor, New York 11724, United States

Funder

National Cancer Institute

Österreichische Forschungsförderungsgesellschaft

Wellcome Trust

Boehringer Ingelheim

Burroughs Wellcome Fund

Structural Genomics Consortium